|
|
||||||||
a CRC Section of Haemopoietic Cell and Gene Therapeutics, Paterson Institute for Cancer Research, Withington, Manchester, United Kingdom;
b CIEMAT, Department of Molecular and Cellular Biology, Avenida Complutense, Madrid, Spain;
c CRC Section of Tumour and Cell Biology, Paterson Institute;
d AmCell Corp., Sunnyvale, CA, USA
Key Words. CD34+ cells • AC133+ • LTC-IC • NOD/SCID mice • Dendritic cells
Dr. E.A. de Wynter, CRC Section of Haemopoietic Cell and Gene Therapeutics, Paterson Institute for Cancer Research, Wilmslow Road, Manchester M20 4BX, United Kingdom.
The AC133 antigen is a novel antigen selectively expressed on a subset of CD34+ cells in human fetal liver, bone marrow, and blood as demonstrated by flow cytometric analyses. In this study, we have further assessed the expression of AC133 on CD34+ cells in hemopoietic samples and found that there was a highly significant difference between normal bone marrow and cord blood versus aphereses (p <0.0001) but not between bone marrow and cord blood.
Most of the clonogenic cells (67%) were contained in the CD34+AC133+ fraction. Compared with cultures of the CD34+AC133 cells, generation of progenitor cells in long-term culture on bone marrow stroma was consistently 10- to 100-fold higher in cultures initiated with CD34+AC133+ cells and was maintained for the 8-10 weeks of culture. Only the CD34+AC133+ cells were capable of repopulating NOD/SCID mice. Human cells were detectable as early as day 20, with increased levels (67%) apparent 40 days post-transplantation. Five thousand CD34+AC133+ cells engrafted about 20% of the mice, while no engraftment was observed in animals transplanted with up to 1.2 x 105 CD34+AC133 cells. The CD34+AC133+ population was also enriched (sevenfold) in dendritic cell precursors, and the dendritic cells generated were functionally active in a mixed lymphocyte reaction assay. AC133+ cells should be useful in the study of cellular and molecular mechanisms regulating primitive hemopoietic cells.
This article has been cited by other articles:
![]() |
M. Amoli, D Carthy, H Platt, and W. Ollier EBV Immortalization of human B lymphocytes separated from small volumes of cryo-preserved whole blood Int. J. Epidemiol., April 1, 2008; 37(suppl_1): i41 - i45. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamamura, K. Ohishi, M. Masuya, E. Miyata, Y. Sugimoto, S. Nakamura, A. Fujieda, H. Araki, and N. Katayama Ex Vivo Culture of Human Cord Blood Hematopoietic Stem/Progenitor Cells Adversely Influences Their Distribution to Other Bone Marrow Compartments After Intra-Bone Marrow Transplantation Stem Cells, February 1, 2008; 26(2): 543 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shao, C. C. White, M. J. Dabrowski, T. J. Kavanagh, M. L. Eckert, and E. P. Gallagher The Role of Mitochondrial and Oxidative Injury in BDE 47 Toxicity to Human Fetal Liver Hematopoietic Stem Cells Toxicol. Sci., January 1, 2008; 101(1): 81 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Christ, K. Lucke, S. Imren, K. Leung, M. Hamilton, A. Eaves, C. Smith, and C. Eaves Improved purification of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity Haematologica, September 1, 2007; 92(9): 1165 - 1172. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Balasubramaniam, C. F. Mervis, A. M. Maxey, N. E. Markham, and S. H. Abman Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1073 - L1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. L. Aranguren, A. Luttun, C. Clavel, C. Moreno, G. Abizanda, M. A. Barajas, B. Pelacho, M. Uriz, M. Arana, A. Echavarri, et al. In vitro and in vivo arterial differentiation of human multipotent adult progenitor cells Blood, March 15, 2007; 109(6): 2634 - 2642. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shao, P. L. Stapleton, Y. S. Lin, and E. P. Gallagher Cytochrome P450 and Glutathione S-Transferase mRNA Expression in Human Fetal Liver Hematopoietic Stem Cells Drug Metab. Dispos., January 1, 2007; 35(1): 168 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Perrella, P Brusini, R Spelat, P Hossain, A Hopkinson, and H S Dua Expression of haematopoietic stem cell markers, CD133 and CD34 on human corneal keratocytes Br. J. Ophthalmol., January 1, 2007; 91(1): 94 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suzuki, Y. Yokoyama, K. Kumano, M. Takanashi, S. Kozuma, T. Takato, T. Nakahata, M. Nishikawa, S. Sakano, M. Kurokawa, et al. Highly Efficient Ex Vivo Expansion of Human Hematopoietic Stem Cells Using Delta1-Fc Chimeric Protein Stem Cells, November 1, 2006; 24(11): 2456 - 2465. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Stuckey, C. A. Carr, E. Martin-Rendon, D. J. Tyler, C. Willmott, P. J. Cassidy, S. J.M. Hale, J. E. Schneider, L. Tatton, S. E. Harding, et al. Iron Particles for Noninvasive Monitoring of Bone Marrow Stromal Cell Engraftment into, and Isolation of Viable Engrafted Donor Cells from, the Heart Stem Cells, August 1, 2006; 24(8): 1968 - 1975. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ma, Y. Ladilov, J. M. Moebius, L. Ong, C. Piechaczek, A. David, A. Kaminski, Y.-H. Choi, W. Li, D. Egger, et al. Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: Bone marrow vs. cord blood-derived cells Cardiovasc Res, July 1, 2006; 71(1): 158 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Thom, V. M. Bhopale, O. C. Velazquez, L. J. Goldstein, L. H. Thom, and D. G. Buerk Stem cell mobilization by hyperbaric oxygen Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1378 - H1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jaatinen, H. Hemmoranta, S. Hautaniemi, J. Niemi, D. Nicorici, J. Laine, O. Yli-Harja, and J. Partanen Global Gene Expression Profile of Human Cord Blood-Derived CD133+ Cells Stem Cells, March 1, 2006; 24(3): 631 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Hess, L. Wirthlin, T. P. Craft, P. E. Herrbrich, S. A. Hohm, R. Lahey, W. C. Eades, M. H. Creer, and J. A. Nolta Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells Blood, March 1, 2006; 107(5): 2162 - 2169. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bornstein, A. I. Flores, M. A. Montalban, M. J. del Rey, J. de la Serna, and F. Gilsanz A Modified Cord Blood Collection Method Achieves Sufficient Cell Levels for Transplantation in Most Adult Patients Stem Cells, March 1, 2005; 23(3): 324 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Vodyanik, J. A. Bork, J. A. Thomson, and I. I. Slukvin Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential Blood, January 15, 2005; 105(2): 617 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Tao, M. Wang, E. D. Voss, R. R. Cocklin, J. A. Smith, S. H. Cooper, and H. E. Broxmeyer Comparative Proteomic Analysis of Human CD34+ Stem/Progenitor Cells and Mature CD15+ Myeloid Cells Stem Cells, November 1, 2004; 22(6): 1003 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Summers, C. M. Heyworth, E. A. de Wynter, C. A. Hart, J. Chang, and N. G. Testa AC133+ G0 Cells from Cord Blood Show a High Incidence of Long-Term Culture-Initiating Cells and a Capacity for More Than 100 Million-Fold Amplification of Colony-Forming Cells In Vitro Stem Cells, September 1, 2004; 22(5): 704 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Umland, H. Heine, M. Miehe, K. Marienfeld, K. H. Staubach, and A. J. Ulmer Induction of various immune modulatory molecules in CD34+ hematopoietic cells J. Leukoc. Biol., April 1, 2004; 75(4): 671 - 679. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Bohmer IL-3-Dependent Early Erythropoiesis Is Stimulated by Autocrine Transforming Growth Factor Beta Stem Cells, March 1, 2004; 22(2): 216 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Denning-Kendall, S. Singha, B. Bradley, and J. Hows Cobblestone Area-Forming Cells in Human Cord Blood Are Heterogeneous and Differ from Long-Term Culture-Initiating Cells Stem Cells, November 1, 2003; 21(6): 694 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Schwartz, B. A. Vance, B. M. Levine, M. Fukazawa, W. G. Telford, D. Cesar, M. Hellerstein, and R. E. Gress Proliferation kinetics of subpopulations of human marrow cells determined by quantifying in vivo incorporation of [2H2]-glucose into DNA of S-phase cells Blood, September 15, 2003; 102(6): 2068 - 2073. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. McGuckin, N. Forraz, M.-O. Baradez, C. Lojo-Rial, D. Wertheim, K. Whiting, S. M. Watt, and R. Pettengell Colocalization Analysis of Sialomucins CD34 and CD164 Stem Cells, March 1, 2003; 21(2): 162 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Abbott, A.-M. Colapietro, Y. Barnes, F. Marini, M. Andreeff, and B. P. Sorrentino Low levels of ABCG2 expression in adult AML blast samples Blood, December 15, 2002; 100(13): 4594 - 4601. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Burger, S. Coetzee, W. L. McKeehan, M. Kan, P. Cook, Y. Fan, T. Suda, R. P. Hebbel, N. Novitzky, W. A. Muller, et al. Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells Blood, November 15, 2002; 100(10): 3527 - 3535. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Stringer, M. J. Forster, B. Mulloy, C. R. Bishop, G. J. Graham, and J. T. Gallagher Characterization of the binding site on heparan sulfate for macrophage inflammatory protein 1alpha Blood, August 13, 2002; 100(5): 1543 - 1550. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. M. Gehling, S. Ergun, U. Schumacher, C. Wagener, K. Pantel, M. Otte, G. Schuch, P. Schafhausen, T. Mende, N. Kilic, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells Blood, May 15, 2000; 95(10): 3106 - 3112. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsumoto, K. Yasui, N. Yamashita, Y. Horie, T. Yamada, Y. Tani, H. Shibata, and T. Nakano In Vitro Proliferation Potential of AC133 Positive Cells in Peripheral Blood Stem Cells, May 1, 2000; 18(3): 196 - 203. [Abstract] [Full Text] |
||||
![]() |
L. Gallacher, B. Murdoch, D. M. Wu, F. N. Karanu, M. Keeney, and M. Bhatia Isolation and characterization of human CD34-Lin- and CD34+Lin- hematopoietic stem cells using cell surface markers AC133 and CD7 Blood, May 1, 2000; 95(9): 2813 - 2820. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Corbeil, K. Roper, A. Hellwig, M. Tavian, S. Miraglia, S. M. Watt, P. J. Simmons, B. Peault, D. W. Buck, and W. B. Huttner The Human AC133 Hematopoietic Stem Cell Antigen Is also Expressed in Epithelial Cells and Targeted to Plasma Membrane Protrusions J. Biol. Chem., February 25, 2000; 275(8): 5512 - 5520. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
